dc.contributor.author | Ramamoorthi, Kartik | |
dc.contributor.author | Lin, Yingxi | |
dc.date.accessioned | 2016-04-08T16:44:56Z | |
dc.date.available | 2016-04-08T16:44:56Z | |
dc.date.issued | 2011-04 | |
dc.identifier.issn | 14714914 | |
dc.identifier.uri | http://hdl.handle.net/1721.1/102223 | |
dc.description.abstract | GABA (γ-aminobutyric acid) is the major inhibitory neurotransmitter in the brain. The GABAergic system is indispensable for maintaining the balance between excitation and inhibition (E/I balance) required for normal neural circuit function. E/I imbalances that result from perturbations in the development of this system, ranging from the generation of inhibitory neurons to the formation of their synaptic connections, have been implicated in several neurodevelopmental disorders. In this review, we discuss how impairments at different stages in GABAergic development can lead to disease states. We also highlight recent studies which show that modulation of the GABAergic system can successfully reverse cognitive deficits in disease models and suggest that therapeutic strategies targeting the GABAergic system could be effective in treating neurodevelopmental disorders. | en_US |
dc.description.sponsorship | McGovern Institute for Brain Research at MIT | en_US |
dc.description.sponsorship | MIT Presidential Marcus Fellowship to Honor Norman B. Leventhal | en_US |
dc.description.sponsorship | Whitehall Foundation (Research Grant) | en_US |
dc.description.sponsorship | John Merck Fund | en_US |
dc.description.sponsorship | Massachusetts Institute of Technology. James H. Ferry Fund | en_US |
dc.description.sponsorship | Simons Foundation. Autism Research Initiative | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.) (Grant MH091220-01) | en_US |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.relation.isversionof | http://dx.doi.org/10.1016/j.molmed.2011.03.003 | en_US |
dc.rights | Creative Commons Attribution-Noncommercial-NoDerivatives | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | en_US |
dc.source | PMC | en_US |
dc.title | The contribution of GABAergic dysfunction to neurodevelopmental disorders | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Ramamoorthi, Kartik, and Yingxi Lin. “The Contribution of GABAergic Dysfunction to Neurodevelopmental Disorders.” Trends in Molecular Medicine 17, no. 8 (August 2011): 452–462. | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences | en_US |
dc.contributor.department | McGovern Institute for Brain Research at MIT | en_US |
dc.contributor.mitauthor | Ramamoorthi, Kartik | en_US |
dc.contributor.mitauthor | Lin, Yingxi | en_US |
dc.relation.journal | Trends in Molecular Medicine | en_US |
dc.eprint.version | Author's final manuscript | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dspace.orderedauthors | Ramamoorthi, Kartik; Lin, Yingxi | en_US |
dc.identifier.orcid | https://orcid.org/0000-0002-7002-1275 | |
mit.license | PUBLISHER_CC | en_US |